← Back to Search

Prebiotic Fibre

Weight Loss for Non-alcoholic Fatty Liver Disease

N/A
Waitlist Available
Led By Raylene A Reimer, PhD, RD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This study is evaluating whether a prebiotic fibre may help treat non-alcoholic fatty liver disease.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Liver Fat
Change in Liver Fibrosis
Change in Liver Injury
Secondary outcome measures
Change in Body Composition
Change in Glucose Tolerance
Change in Glycemic Control
+5 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Weight LossExperimental Treatment1 Intervention
All participants will be supported through Registered Dietitian visits to achieve approximately 10% weight loss.
Group II: Prebiotic FibreExperimental Treatment2 Interventions
The intervention group will receive two 8g packets/day of prebiotic fibre to add to 250 ml of water and consume 30 minutes prior to breakfast and dinner.
Group III: PlaceboPlacebo Group2 Interventions
The control group will receive two 3g packets/day of maltodextrin to add to 250 ml of water and consume 30 minutes prior to breakfast and dinner.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prebiotic fibre
2015
N/A
~50
Weight Loss
2008
Completed Phase 3
~1460

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
787 Previous Clinical Trials
846,263 Total Patients Enrolled
2 Trials studying Non-alcoholic Fatty Liver Disease
96 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,338 Previous Clinical Trials
25,751,473 Total Patients Enrolled
11 Trials studying Non-alcoholic Fatty Liver Disease
770 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Raylene A Reimer, PhD, RDPrincipal InvestigatorUniversity of Calgary
6 Previous Clinical Trials
422 Total Patients Enrolled
1 Trials studying Non-alcoholic Fatty Liver Disease
14 Patients Enrolled for Non-alcoholic Fatty Liver Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease
Raylene Reimer 2015. "Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02568605.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top